Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response

In patients with light chain (AL) amyloidosis, clinical benefit depends on profound hematologic response translating into organ, especially cardiac or renal, response. Treatment is aimed at rapidly...